Literature DB >> 24480570

28S rRNA is inducibly pseudouridylated by the mTOR pathway translational control in CHO cell cultures.

Franck C Courtes1, Chen Gu2, Niki S C Wong3, Peter C Dedon2, Miranda G S Yap1, Dong-Yup Lee4.   

Abstract

The mTOR pathway is a conserved master regulator of translational activity that influences the fate of industrially relevant CHO cell cultures, yet its molecular mechanisms remain unclear. Interestingly, rapamycin specific inhibition of the mTOR pathway in CHO cells was found to down-regulate the small nucleolar RNA U19 (snoRNA U19) by 2-fold via translatome profiling. snoRNA U19 guides the two most conserved pseudouridylation modifications on 28S ribosomal RNA (rRNA) that are important for the biogenesis and proper function of ribosomes. In order to further understand the role of snoRNA U19 as a potential player in the mTOR pathway, we measured 28S rRNA pseudouridylation upon rapamycin treatments and/or snoRNA U19 overexpression conditions, thereby characterizing the subsequent effects on ribosome efficiency and global translation by polysome profiling. We showed that 28S rRNA pseudouridylation was increased by rapamycin treatment and/or overexpression of snoRNA U19, but only the latter condition improved ribosome efficiency toward higher global translation, thus implying that the mTOR pathway induces pseudouridylation at different sites along the 28S rRNA possibly with either positive or negative effects on the cellular phenotype. This discovery of snoRNA U19 as a new downstream effector of the mTOR pathway suggests that cell engineering of snoRNAs can be used to regulate translation and improve cellular growth in CHO cell cultures in the future.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CHO cells culture; Inducible pseudouridylation; Translatome; mTOR pathway; snoRNA U19

Mesh:

Substances:

Year:  2014        PMID: 24480570      PMCID: PMC4310699          DOI: 10.1016/j.jbiotec.2014.01.024

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  36 in total

1.  Crystal structure of the ribosome at 5.5 A resolution.

Authors:  M M Yusupov; G Z Yusupova; A Baucom; K Lieberman; T N Earnest; J H Cate; H F Noller
Journal:  Science       Date:  2001-03-29       Impact factor: 47.728

Review 2.  Synthesis of the translational apparatus is regulated at the translational level.

Authors:  O Meyuhas
Journal:  Eur J Biochem       Date:  2000-11

3.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

4.  The host gene for intronic U17 small nucleolar RNAs in mammals has no protein-coding potential and is a member of the 5'-terminal oligopyrimidine gene family.

Authors:  P Pelczar; W Filipowicz
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

5.  Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5'-terminal oligopyrimidine gene family reveals common features of snoRNA host genes.

Authors:  C M Smith; J A Steitz
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

6.  Site-specific pseudouridine formation in preribosomal RNA is guided by small nucleolar RNAs.

Authors:  P Ganot; M L Bortolin; T Kiss
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

7.  Ribosome structure and activity are altered in cells lacking snoRNPs that form pseudouridines in the peptidyl transferase center.

Authors:  Thomas H King; Ben Liu; Ryan R McCully; Maurille J Fournier
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

Review 8.  When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells.

Authors:  L E Maquat
Journal:  RNA       Date:  1995-07       Impact factor: 4.942

9.  A snoRNA that guides the two most conserved pseudouridine modifications within rRNA confers a growth advantage in yeast.

Authors:  Gwenael Badis; Micheline Fromont-Racine; Alain Jacquier
Journal:  RNA       Date:  2003-07       Impact factor: 4.942

10.  Human U19 intron-encoded snoRNA is processed from a long primary transcript that possesses little potential for protein coding.

Authors:  M L Bortolin; T Kiss
Journal:  RNA       Date:  1998-04       Impact factor: 4.942

View more
  13 in total

1.  Transcriptome-Wide Identification of Pseudouridine Modifications Using Pseudo-seq.

Authors:  Thomas M Carlile; Maria F Rojas-Duran; Wendy V Gilbert
Journal:  Curr Protoc Mol Biol       Date:  2015-10-01

2.  H/ACA snoRNA levels are regulated during stem cell differentiation.

Authors:  Kathleen L McCann; Sanam L Kavari; Adam B Burkholder; Bart T Phillips; Traci M Tanaka Hall
Journal:  Nucleic Acids Res       Date:  2020-09-04       Impact factor: 16.971

Review 3.  Pseudouridine as a novel biomarker in prostate cancer.

Authors:  Jennifer A Stockert; Rachel Weil; Kamlesh K Yadav; Natasha Kyprianou; Ashutosh K Tewari
Journal:  Urol Oncol       Date:  2020-07-22       Impact factor: 3.498

4.  Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome.

Authors:  Xiaoyu Li; Ping Zhu; Shiqing Ma; Jinghui Song; Jinyi Bai; Fangfang Sun; Chengqi Yi
Journal:  Nat Chem Biol       Date:  2015-06-15       Impact factor: 15.040

5.  An expanding universe of mRNA modifications.

Authors:  Samie R Jaffrey
Journal:  Nat Struct Mol Biol       Date:  2014-11       Impact factor: 15.369

Review 6.  Pseudouridine: still mysterious, but never a fake (uridine)!

Authors:  Felix Spenkuch; Yuri Motorin; Mark Helm
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

Review 7.  Regulation and Function of RNA Pseudouridylation in Human Cells.

Authors:  Erin K Borchardt; Nicole M Martinez; Wendy V Gilbert
Journal:  Annu Rev Genet       Date:  2020-09-01       Impact factor: 16.830

8.  Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA.

Authors:  Schraga Schwartz; Douglas A Bernstein; Maxwell R Mumbach; Marko Jovanovic; Rebecca H Herbst; Brian X León-Ricardo; Jesse M Engreitz; Mitchell Guttman; Rahul Satija; Eric S Lander; Gerald Fink; Aviv Regev
Journal:  Cell       Date:  2014-09-11       Impact factor: 41.582

Review 9.  Targeting snoRNAs as an emerging method of therapeutic development for cancer.

Authors:  Di Zhang; Juan Zhou; Jie Gao; Ri-Ying Wu; Ying-Long Huang; Qin-Wen Jin; Jian-Si Chen; Wei-Zhong Tang; Lin-Hai Yan
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

Review 10.  The emerging landscape of small nucleolar RNAs in cell biology.

Authors:  Fabien Dupuis-Sandoval; Mikaël Poirier; Michelle S Scott
Journal:  Wiley Interdiscip Rev RNA       Date:  2015-04-16       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.